Some Children Now Prescribed GLP-1 Weight-Loss Drugs

Pediatric use is limited to children who meet clinical criteria, and cost remains a major barrier for many families.

Updated on Nov. 2, 2026 in Weight Loss

Photograph of a folded white lab coat draped over a clean pale exam table in a bright, quiet clinic room. — Doctors are now prescribing GLP-1 weight-loss drugs to some children who meet clinical criteria, though cost remains a major barrier for many families. AI Illustration. Upload story photo >

Live Poll

Do you think doctors should prescribe GLP-1 weight-loss drugs to some children?

Doctors are prescribing GLP-1 weight-loss drugs, which have been popular with adults, to some children. Families of children who are candidates for these medications should discuss eligibility and cost with a pediatric clinician, since price remains a barrier for many households.

Why it matters

For some children, healthy eating and exercise alone are not enough to manage weight, and the reasons cited include genetics and hormonal dysregulation. Expanding these prescriptions to younger patients changes the options available for childhood obesity care, which is why the practice is drawing attention now.

The information comes from expert descriptions of current prescribing practice rather than a controlled trial. Experts identify a BMI at or above the 95th percentile as the profile of an ideal candidate, and state that lifestyle changes alone have not worked for these children.

The players

Magnolia Woods Elementary

An elementary school in Baton Rouge, Louisiana, whose students are learning about healthy eating and exercise.

The details

GLP-1 agonists are described by experts as reducing food noise and food chatter, meaning the constant preoccupation with eating that can drive overeating. They are also described as anti-inflammatory. Because these drugs are established for adults, their use in children is an extension that clinicians are weighing case by case.

Article on pediatric GLP-1 prescriptions published November 2, 2026.

Health Landscape

GLP-1 weight-loss drugs have been prescribed mainly to adults, and their extension to children marks a shift in who the treatment is considered for. The practice sits alongside a statewide push in Louisiana to lower obesity rates through school-based education on eating and exercise.

If your child has a weight concern that diet and activity have not resolved, it is worth raising GLP-1 options with a pediatrician, who can assess whether a child meets the criteria. Cost is a real consideration, so ask about coverage before assuming the medication is available.

The takeaway

Pediatric use of GLP-1 drugs is an expanding option for children with obesity that has not responded to lifestyle changes. Ask a pediatrician whether your child's BMI and history make them a candidate, and check insurance coverage early.